Abstract
Objective: Heated intraperitoneal (HIPEC) and intrathoracic chemotherapy (HITEC) can be used to treat peritoneal dissemination of gynecologic cancers following cytoreductive surgery. The aim of this study was to investigate patient characteristics, disease outcomes, and perioperative adverse outcomes in women with gynecologic cancer receiving surgical debulking with HIPEC or HITEC.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
